In the BioHarmony Drug Report Database
Loteprednol etabonate
Alrex, Eysuvis, Inveltys, Lotemax, Lotemax Sm (loteprednol etabonate) is a small molecule pharmaceutical. Loteprednol etabonate was first approved as Alrex on 1998-03-09. It is used to treat allergic conjunctivitis, bacterial conjunctivitis, edema, inflammation, and iritis amongst others in the USA. Lotemax’s patents are valid until 2036-12-23 (FDA).
Trade Name
|
Alrex, Eysuvis, Inveltys, Lotemax, Lotemax Sm |
|---|---|
Common Name
|
loteprednol etabonate |
ChEMBL ID
|
CHEMBL1200865 |
Indication
|
allergic conjunctivitis, bacterial conjunctivitis, edema, inflammation, iritis, keratitis, rosacea, viral conjunctivitis |
Drug Class
|
Prednisone and prednisolone derivatives |
Image (chem structure or protein)